Evernorth Health Services' initiative to offer Humira biosimilar with $0 out-of-pocket costs for patients. Save an average of ...

Evernorth's Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs, the company ...

Moreover, the product will be available to patients at Accredo, which is the PBM’s specialty pharmacy. What CVS Caremark is ...

Tricare beneficiaries may now receive specialty drugs at lower copays through Tricare Home Delivery, according to the ...

Q1 2024 Earnings Call Transcript May 2, 2024 Cigna Corporation beats earnings expectations. Reported EPS is $6.47, ...

In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar ...

AbbVie (ABBV) shares were down 6% in the wake of its Q1 earnings report and news that Cigna (CI) plans to offer a Humira ...

Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no out-of-pocket payment to ...

Evernorth Health Services will offer Humira biosimilar products with no out-of-pocket cost through its Accredo specialty ...

Operator instructions] As a reminder, ladies and gentlemen, this conference, including the Q&A session, is being recorded. We ...

For many employers, unions, municipalities and other health plan sponsors that choose to work with Accredo as part of their specialty pharmacy network offering, this represents an opportunity for ...